Gilead Sciences, Inc.
$GILD
Public valuation for Gilead Sciences, Inc. (GILD). Fair value, signal, and key metrics — no sign-in required.
Current Price
$134.43
Fairly Valued
Fair Value Estimate
$135
🚧
Turnaround
Negative earnings but showing signs of recovery
Analyst Consensus
Target: $157.83
17% higher than current
Key Metrics
Market Cap
$166.9B
Forward P/E
15.2x
Operating Margin
37.1%
Revenue Growth
4.0%
PEG Ratio
2.09
Get free watchlist alerts
Join the waitlist for valuation updates on $GILD and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.